Ultrasound-guided pulsed radiofrequency treatment for knee osteoarthritis
Official title: Ultrasound-Guided Pulsed Radiofrequency Of The Genicular Nerves In The Treatment Of Patients With Osteoarthritis Knee Pain: Randomized, Double-Blind, Placebo Controled Trial
Run by Hospital Son Llatzer · NCT02915120 · Data updated 2026-11-12
This study is testing whether a new ultrasound-guided treatment for knee pain can help people with chronic knee osteoarthritis feel better and use less pain medication.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 142 (estimated) |
| Sponsor | Hospital Son Llatzer Academic / other |
| Locations | 1 site (Palma, Balear Islands) |
| Status | Recruiting |
| Started | March 27, 2017 |
| Main results expected | December 2024 |
| Study ends | December 2024 |
| Registry record updated | November 12, 2024 |
| Trial ID | NCT02915120 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals with chronic knee pain due to primary osteoarthritis, experiencing significant pain despite conventional therapies.
✕Probably not a fit
Patients with secondary osteoarthritis or those who have had recent corticosteroid injections may not benefit from this treatment.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of ultrasound-guided pulsed radiofrequency treatment on the genicular nerves in patients suffering from chronic knee osteoarthritis. Participants will undergo a double diagnostic genicular nerve block followed by either real or sham pulsed radiofrequency treatment. The primary focus is to assess improvements in pain, function, and reduction in analgesic use over time. Given the increasing prevalence of knee osteoarthritis, this approach seeks to provide an alternative to conventional treatments and surgical options.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce pain and improve function for patients with chronic knee osteoarthritis.
How similar studies have gone: Similar studies have shown promising results with ultrasound-guided pulsed radiofrequency, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Chronic knee pain with pain intensity of at least 4 out 10 on the VAS on most or all days for more than 3 months * Patients of either sex with primary osteoarthritis of one or both knees fulfilling diagnostic criteria for osteoarthritis knee laid down by American College of Rheumatology. * Patients also had to have a Kellgren-Lawrence (radiologic criterion) score of at least 2 * Pain resistant to conventional therapy including NSAIDs, opioids, muscle relaxants, oral steroids, physical therapy, and intra-articular injection therapy. Exclusion Criteria: * The patients with secondary osteoarthritis of knees * Associated systemic arthropathies, e.g. rheumatoid arthritis and gout * Previous radiofrequency ablation treatment for similar symptoms. * Intra-articular knee corticosteroid or hyaluronic acid injection in the past 3 months. * Active systemic or local infections at the site of proposed needle and electrode placement. * Coagulopathy or other bleeding disorder * Cognitive deficit. * Unstable medical or psychiatric illness. * Previous knee joint replacement surgery * Patients missing two or more appointments consecutively were excluded from the study
Where it's running
-
Son Llatzer University Hospital
Palma, Balear Islands, Spain Recruiting
Study contacts
- Principal investigator: Javier Mata, MD — Son Llatzer University Hospital
- Study coordinator: Javier Mata, MD
- Email: jmata@hsll.es
- Phone: 0034871201233
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SVF cellular mix, secretome, and knee response in osteoarthritis
This study tests the cellular composition and secretome of research-only adipose-derived SVF in adults with knee OA who are already planned to receive an autologous SVF injection as part of their care.
-
Effect of a Resistance Exercise Program on IGF-1 Levels in Knee Osteoarthritis
A structured 8-week resistance exercise program is being tested to see if it changes blood IGF-1 levels and improves knee OA symptoms in adults with knee OA and metabolic traits.
-
2-mm subchondral drilling vs sequential 4-mm and 2-mm drilling during CARTISTEM implantation for knee cartilage defects
This study tests whether drilling the knee with a 2-mm drill alone works as well as sequential 4-mm then 2-mm drilling when combined with CARTISTEM treatment for medial knee cartilage defects.
-
Undenatured Type II Collagen for Knee Osteoarthritis Pain (Three-Arm Trial)
This study tests whether taking undenatured type II collagen capsules once daily for 4 months can reduce knee pain in adults with knee osteoarthritis, compared with two collagen formulations and a placebo.
-
Serum Fetuin‑A and COMP levels in knee osteoarthritis
This study tests whether levels of Fetuin‑A and COMP in the blood relate to how severe knee osteoarthritis is in patients compared with healthy volunteers.
-
Pain relief for knee osteoarthritis: a 2nd phase study of LY4065967 vs placebo
Researchers are testing whether LY4065967 can help reduce knee pain from osteoarthritis in adults, compared with placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.